Early, encouraging data for glioblastoma treatment reported at ASCO
All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham have exceeded both their median and expected progression-free survivals. Two patients, ...
Jun 10, 2022
0
9
